MALAT1 and familial pancreatic carcinoma: The main findings of the study were as follows: MALAT1 promotes oncogenesis and enhances KRAS/mitogen-activated protein kinase (MAPK) signalling pathway activation in pancreatic cancer at least in part through a direct interaction with miR-217.